Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients.

Giustina, A; Bossoni, S; Bodini, C; Cimino, A; Pizzocolo, G; Schettino, M; Wehrenberg, W B

Giustina, A; Bossoni, S; Bodini, C; Cimino, A; Pizzocolo, G; Schettino, M; Wehrenberg, W B.

Affiliation

Giustina A; Cattedra di Clinica Medica, University of Brescia, Italy.

Acta Endocrinol (Copenh) ; 125(5): 510-7, 1991 Nov.

Article in En | MEDLINE | ID: mdl-1759540

Subject(s)

Diabetes Mellitus, Type 1/drug therapy; Growth Hormone-Releasing Hormone/therapeutic use; Growth Hormone/blood; Growth Hormone/therapeutic use; Pyridostigmine Bromide/therapeutic use; Administration, Oral; Adolescent; Adult; Diabetes Mellitus, Type 1/blood; Double-Blind Method; Drug Therapy, Combination; Female; Growth Hormone/administration & dosage; Growth Hormone-Releasing Hormone/administration & dosage; Humans; Injections, Intravenous; Male; Middle Aged; Pyridostigmine Bromide/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyridostigmine Bromide / Growth Hormone / Growth Hormone-Releasing Hormone / Diabetes Mellitus, Type 1 Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Acta Endocrinol (Copenh) Year: 1991 Document type: Article Affiliation country: Italy Country of publication: Denmark

Search on Google

Add to My VHL

XML

PubMed Links